Journal of Sleep Disorders & Therapy
Open Access

Influences of Mirtazapine on Chronic Pain-related Sleep Disorder in Regulating the Neurotransmitters

Leonie Belleville^{* *}Correspondence: Dr. Leonie Belleville, Department of Psychiatry, University of Amsterdam, Amsterdam, The Netherlands, Email:

Author info »

Description

Doctors often prescribe the antidepressant mirtazapine to treat depression. It is the Remeron brand-name drug's generic version. The group of medicines known as tetracyclic antidepressants includes mirtazapine. These drugs assist in regulating the neurotransmitters, or chemical messengers, in the brain that control mood. It has been demonstrated that mirtazapine affects various stages of sleep. It shortens the early, light stages of sleep, elongates deep sleep and also slightly reduces REM sleep (dream sleep). While mirtazapine off-label use could appear like a solution for insomnia, it has certain negative side effects [1]. Tetracyclic antidepressants, such as mirtazapine, which is also marketed under the name Remeron, are a class of medication. It is permitted by the Food and Drug Administration (FDA) of the United States to treat major depressive disorder. Various anxiety disorders, obsessive-compulsive disorder, and insomnia may all be treated with mirtazapine "off-label" by doctors. Neurotransmitters, a class of chemical messengers, are more prevalent in the brain after taking mirtazapine [2]. It particularly enhances the effects of noradrenaline and serotonin. These neurotransmitters assist in the regulation of mood, stress, and sleep/wake cycles. Mirtazapine is typically prescribed by medical professionals to treat depression. Mirtazapine is also beneficial in treating persons with the following subtypes of depression, according to a review of research Trusted Source: Depression and anxiety related to alcoholism, melancholic depression, treatment-resistant depression, geriatric depression in general we also mentioned the mirtazapine could successfully assist with: Nausea following surgery; sleep issues; poor appetite; and pain management. Both oral tablets and dissolvable tablets are available in the form of mirtazapine. Both types of dosing are the same. The Food and Drug Administration (FDA) recommends a 15 milligramme (mg) daily in the starting dose of the patient. Preferably, people should take it in the evening before bed. The daily dosage for mirtazapine should be between 15 mg and 45 mg. After 1-2 weeks, a person may progressively increase the dosage with a doctor's approval [3,4]. The dosages for the pills are as follows: 15 mg, 30 mg, and 45 mg Some medical specialists might advise dividing the dose in half and taking one half twice day. Mirtazapine helps in improved the appetite, nausea, and sleep. Additionally, it has side effects that could help with pain management and promote weight gain.

The following conditions may also be treated with mirtazapine off-label: Post-Traumatic Stress Disorder (PTSD), typically in conjunction with SSRIs; insomnia; panic disorder; social anxiety disorder; fibromyalgia; Mirtazapine Adverse Reactions (MAR). The usage of mirtazapine is linked to a number of adverse effects. The most typical examples are:

• Exhaustion

• Dizziness

• Dry mouth

• Anxiety or confusion nausea or vomiting

• Constipation a heightened

• Sense of appetite weight gain

Conclusion

The oral pill should be taken whole without chewing. The dissolvable tablet may be recommended by a medical expert if a patient has trouble swallowing medicines. A dissolvable tablet must be taken by breaking it free of the blister packaging, placing it on the tongue, and waiting for it to dissolve. It should disintegrate rather rapidly. People should take their medications as directed and not try to change their dosage on their own or purposely miss doses. The FDA has approved mirtazapine for the primary use of treating depression. It has the advantage of providing relief from depressive and anxiety-related symptoms of depression more quickly than certain other drugs.

References

1. Miljatovic AM. P-1354-Comparative effects of venlafaxine and mirtazapine on sleep physiology measures in patients with major depressive disorder and insomnia. Euro Psych. 2012;27(S1):1-10.

   [Crossref] [Google Scholar]

2. McGregor C, Srisurapanont M, Mitchell A, Wickes W, White JM. Symptoms and sleep patterns during inpatient treatment of methamphetamine withdrawal: A comparison of mirtazapine and modafinil with treatment as usual. J Subst Abuse Treat. 2008;35(3):334-342.

   [Crossref] [Google Scholar] [PubMed]

3. Castillo JL, Menendez P, Segovia L, Guilleminault C. Effectiveness of mirtazapine in the treatment of Sleep Apnea/Hypopnea Syndrome (SAHS). Sleep Med. 2004;5(5):507-508.

   [Crossref] [Google Scholar] [PubMed]

4. Ruigt GS, van Delft AM, Broekkamp CL. Characteristic effects of mirtazapine and other antidepressants on rat sleep EEG. Euro Psych. 1996;11(S4):335s-336s.

   [Crossref] [Google Scholar]